U.S. FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Blenrep approved in Australia for use in adults with relapsed or refractory multiple myeloma as...

Sichuan Biokin Pharmaceutical announces acceptance of the New Drug Application for Iza-Bren (an EGFR×HER3 Bispecific...

Avenzo Therapeutics granted Fast Track Designation for AVZO-103, a potential best-in-class nectin4/TROP2 bispecific ADC, for...

IntoCell receives FDA IND approval for advanced solid tumor treatment ‘ITC-6146RO’

Aptis and Cobx Bio partner to develop DAC cancer drugs